AdvanSix Provides Update on Third Quarter Turnaround and Expected Financial Results
PARSIPPANY, N.J.–(BUSINESS WIRE)–AdvanSix (NYSE: ASIX) announced a preliminary update on its third quarter planned turnaround…
PARSIPPANY, N.J.–(BUSINESS WIRE)–AdvanSix (NYSE: ASIX) announced a preliminary update on its third quarter planned turnaround…
***1:30 p.m. Friday, October 7, 1600 Veterans Boulevard, Metairie, LA 70005*** METAIRIE, La.–(BUSINESS WIRE)–Home Bank…
Gross Proceeds of $30.5 Million Raised YAVNE, Israel, Oct. 07, 2022 (GLOBE NEWSWIRE) — MediWound…
TOKYO, Oct 7, 2022 – (JCN Newswire) – NEC Corporation (TSE: 6701) will launch the…
Prestigious International Awards Program Recognizes Outstanding Information Security Products and Companies AUSTIN, Texas and AUCKLAND,…
TOKYO & HAMBURG, Oct 7, 2022 – (JCN Newswire) – Olympus Corporation (Olympus), a global…
TOKYO, Oct 7, 2022 – (JCN Newswire) – PT Hitachi Astemo Bekasi Manufacturing, located in…
Industrial will be the leading vertical followed by Automotive with highest CAGR in 2030 BOSTON–(BUSINESS…
NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or…
BOCA RATON, Fla., Oct. 06, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First…
TOKYO, Oct 7, 2022 – (JCN Newswire) – ADVA (FSE: ADV) and NEC Corporation (TSE:…
SYDNEY, AU, Oct 7, 2022 – (ACN Newswire) – Novotech, the leading Asia Pacific biotech…
BioNTech and Australia’s State of Victoria will establish an mRNA research and innovation center to…
Nearly 900 attendees and over 300 customers attend event celebrating Boundless Digital Invention SAN DIEGO–(BUSINESS…
A preliminary analysis of the University of Oxford’s open label, prospective real-world evidence study, PANORAMIC,…
PHOENIX–(BUSINESS WIRE)–Carvana Co. (NYSE: CVNA), the leading e-commerce platform for buying and selling used cars,…
Sale process of Company’s SaaS assets completed in accordance with procedures approved by the order…
GigNet’s Fiber-to-the-Home (FTTH) Internet Services Will Enable Developers Grupo ROA to Create a Pioneering ‘Smart…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…
ALPHA2 Trial, Evaluating ALLO-501A in Relapsed/Refractory Large B Cell Lymphoma Patients, is Designed to Leverage…